S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

UPC Universe Pharmaceuticals Inc

1.125

-0.255 (-18.48%)

Last Updated: 08:57:24

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Universe Pharmaceuticals (NASDAQ:UPC)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Universe Pharmaceuticals Charts.

Universe Pharmaceuticals (NASDAQ:UPC)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Universe Pharmaceuticals Charts.

Universe Pharmaceuticals Inc News

Form 424B5 - Prospectus [Rule 424(b)(5)]
Monday 9 December 2024 (18 hours ago) • Edgar (US Regulatory)

Universe Pharmaceuticals INC Announces $15 Million Registered Direct Offering
Monday 9 December 2024 (1 day ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 13 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Universe Pharmaceuticals INC Announces Share Consolidation
Wednesday 13 November 2024 (4 weeks ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 1 November 2024 (1 month ago) • Edgar (US Regulatory)

Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Friday 1 November 2024 (1 month ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 10 October 2024 (2 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 27 September 2024 (2 months ago) • Edgar (US Regulatory)

Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024
Friday 20 September 2024 (3 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 20 September 2024 (3 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 3 September 2024 (3 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 18 July 2024 (5 months ago) • Edgar (US Regulatory)

More Universe Pharmaceuticals Inc News Articles

GNCC Capital (CE)

Movement Industries (PK)

TransCode Therapeutics

Revance Therapeutics

Intergrated Cannabis Sol... (PK)

Clean Vision (QB)

Asia Broadband (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions